LSD Caught in Action: PET-MRI Reveals How the Psychedelic Grips the Human Brain
A landmark PET-MRI study has for the first time quantified how LSD occupies serotonin 2A receptors in the living human ...
Tag: Pharmacokinetics
Conformation-Selective PI3Kδ Inhibitor Roginolisib Shows Safety and Survival Signals in First-in-Human Cancer Trial
A first-in-human trial shows that the conformation-selective PI3Kδ inhibitor roginolisib is well tolerated in advanced cancers and is associated with ...
Quantum Chemistry Reveals Hidden Power of a Fluorinated Sulfonamide Molecule
A comprehensive DFT study of the fluorinated triazolopyrimidine sulfonamide DTPB reveals strong nonlinear optical performance, stable delocalized electronic structure, and ...
Plant Flavonoids Emerge as Multi-Target Weapon Against Drug-Resistant Tuberculosis
A new review maps how plant-derived flavonoids attack tuberculosis through multiple molecular mechanisms while outlining the structural features and delivery ...
New Antibody-Drug Conjugate SCR-A008 Shows Powerful Tumor Suppression in Gastric Cancer Models
A novel CDH17-targeted antibody-drug conjugate called SCR-A008 achieved sustained tumor inhibition in gastric cancer PDX models, with a paclitaxel combination ...
Where mRNA Vaccines Really Go: New Review Maps the Journey of Lipid Nanoparticles Through the Body
A new review synthesizes preclinical and clinical evidence showing that lipid nanoparticle biodistribution, mRNA persistence, and protein expression are distinct ...
Blood Levels of Liver Cancer Drug Lenvatinib Predict Who Responds to Treatment
A multi-omics study of 194 liver cancer patients shows that lenvatinib blood concentrations above 26.5 ng/mL predict treatment response, while ...
Epilepsy drugs may quietly undermine hormonal birth control, study finds
A University of Pittsburgh-led study of Medicaid data found that nearly one-third of epilepsy patients prescribed susceptible hormonal contraceptives also ...
Stopping Ozanimod: Large Trial Follow-Up Finds Relapses Return Mildly, With No Sign of Rebound
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod, ...
Self-Learning Controller Keeps Drug Levels on Target in the Living Brain
Researchers have demonstrated an adaptive feedback controller that measures drug concentrations in the living brain in real time, learns each ...
Simulated Patients Replace Human Trials in Virtual Test of Roxithromycin Drug Equivalence
Chinese researchers validated a physiologically based pharmacokinetic model of roxithromycin and used it to run a virtual bioequivalence trial in ...
Human Organs on Chips Recreate Body’s Niches to Predict Drug Safety
A Stanford-led review in Nature Biomedical Engineering maps how multi-organ tissue chips that preserve each organ's native niche could transform ...
Flavonoids Influence Escitalopram Metabolism: Study Insights
In recent years, the intersection of botany and pharmacology has garnered substantial interest among researchers. This fascination has led to ...
Chemometric Modeling: Predicting Drug Half-Life for Future Therapies
In a groundbreaking study set to be published in the journal Molecular Diversity, researchers led by Pratik Samanta, along with ...
Unveiling the Chemical Composition and Blood-Absorbed Components of Shenqi Fuzheng Extract Through UPLC-Triple-TOF/MS Analysis
Shenqi Fuzheng (SQ) is a traditional Chinese medicine formula known for its ability to bolster immune function and replenish Qi, ...
POPULAR NEWS
-
Case Report Explores Caplacizumab in Late-Diagnosed Congenital Thrombotic Thrombocytopenic Purpura
-
Multitask Cambrian Model Improves Protein Melting Temperature Prediction
-
Vasopressors Exert Divergent Immunomodulatory Effects Across a Spectrum in Septic Shock
-
Study Identifies Key Drivers Shaping Salmonid Gill Microbiomes in Aquaculture